ArticleFrontiers in oncology2023

Corrigendum: The prognosis value of CONUT and SIS score for recurrent or metastatic esophageal squamous cell carcinoma patients treated with second-line immunotherapy.

Xiao-Han Zhao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.